Takeda Says Most Actos Claimants Want In On $2.4B Deal
Takeda Pharmaceutical Company Ltd. said Friday that more than 96 percent of claimants have sought a share of the Japanese drugmaker's proposed deal of up to $2.4 billion to resolve claims...To view the full article, register now.
Already a subscriber? Click here to view full article